The relationship between performance validity Test failure, fatigue, and psychological functioning in Long COVID.

IF 3 3区心理学 Q2 CLINICAL NEUROLOGY Clinical Neuropsychologist Pub Date : 2025-03-08 DOI:10.1080/13854046.2025.2476798

Greta N Minor, Olivia R Kessler, Laura Fry, Brooke Huizenga, Sara Johnson, Savana M Naini, Chen Shen, Sophie J Wiitala, Michael R Basso, Courtney L Eskridge, Erin Holker, Allison M Logemann, Eric J Waldron, Douglas M Whiteside

{"title":"The relationship between performance validity Test failure, fatigue, and psychological functioning in Long COVID.","authors":"Greta N Minor, Olivia R Kessler, Laura Fry, Brooke Huizenga, Sara Johnson, Savana M Naini, Chen Shen, Sophie J Wiitala, Michael R Basso, Courtney L Eskridge, Erin Holker, Allison M Logemann, Eric J Waldron, Douglas M Whiteside","doi":"10.1080/13854046.2025.2476798","DOIUrl":null,"url":null,"abstract":"Objective: At times, patients with Long COVID fail performance validity tests (PVTs) for cognitive measures and symptom validity tests (SVTs) embedded in formal personality measures. This is the first study, to our knowledge, to examine whether self-reported symptoms on the Personality Assessment Inventory (PAI) and the Modified Fatigue Impact Scale (MFIS) were related to performance validity in Long COVID patients. Method: Participants were 175 individuals diagnosed with Long COVID who completed four PVTs, the MFIS, and the PAI. There was evidence for nots based on medical records review for 25.71% of the patients. Based on PVT performances, patients were assigned to one of three groups: Pass group (no PVT failures), Intermediate group (1 PVT failure), or Fail group (2+ PVT failures). Results: 84.57% of participants were in the Pass group, 9.14% in the Intermediate group, and 6.29% in the Fail group. There was a not a significant difference in external incentive frequency between groups. Only one significant group difference on the PAI scales and subscales was found, with slightly greater somatization symptoms (SOM-S) reported in the Fail group relative to the Pass group (η2 = .03). The MFIS was not significantly different between groups. Conclusions: These findings suggest that PVT failure is not associated with fatigue or PAI responses, except on the somatization subscale.","PeriodicalId":55250,"journal":{"name":"Clinical Neuropsychologist","volume":" ","pages":"1-16"},"PeriodicalIF":3.0000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychologist","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/13854046.2025.2476798","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: At times, patients with Long COVID fail performance validity tests (PVTs) for cognitive measures and symptom validity tests (SVTs) embedded in formal personality measures. This is the first study, to our knowledge, to examine whether self-reported symptoms on the Personality Assessment Inventory (PAI) and the Modified Fatigue Impact Scale (MFIS) were related to performance validity in Long COVID patients. Method: Participants were 175 individuals diagnosed with Long COVID who completed four PVTs, the MFIS, and the PAI. There was evidence for nots based on medical records review for 25.71% of the patients. Based on PVT performances, patients were assigned to one of three groups: Pass group (no PVT failures), Intermediate group (1 PVT failure), or Fail group (2+ PVT failures). Results: 84.57% of participants were in the Pass group, 9.14% in the Intermediate group, and 6.29% in the Fail group. There was a not a significant difference in external incentive frequency between groups. Only one significant group difference on the PAI scales and subscales was found, with slightly greater somatization symptoms (SOM-S) reported in the Fail group relative to the Pass group (η² = .03). The MFIS was not significantly different between groups. Conclusions: These findings suggest that PVT failure is not associated with fatigue or PAI responses, except on the somatization subscale.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical Neuropsychologist 医学-临床神经学

CiteScore

8.40

自引率

12.80%

发文量

审稿时长

6-12 weeks

期刊介绍： The Clinical Neuropsychologist (TCN) serves as the premier forum for (1) state-of-the-art clinically-relevant scientific research, (2) in-depth professional discussions of matters germane to evidence-based practice, and (3) clinical case studies in neuropsychology. Of particular interest are papers that can make definitive statements about a given topic (thereby having implications for the standards of clinical practice) and those with the potential to expand today’s clinical frontiers. Research on all age groups, and on both clinical and normal populations, is considered.